Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, China SXT Pharmaceuticals Inc’s stock clocked out at $1.02, up 3.03% from its previous closing price of $0.99. In other words, the price has increased by $3.03 from its previous closing price. On the day, 0.77 million shares were traded. SXTC stock price reached its highest trading level at $1.08 during the session, while it also had its lowest trading level at $0.9449.
Ratios:
To gain a deeper understanding of SXTC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.06.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SXTC now has a Market Capitalization of 576843 and an Enterprise Value of -7150570. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.34 while its Price-to-Book (P/B) ratio in mrq is 3.66. Its current Enterprise Value per Revenue stands at -4.199 whereas that against EBITDA is 0.541.
Stock Price History:
Over the past 52 weeks, SXTC has reached a high of $9.38, while it has fallen to a 52-week low of $0.94. The 50-Day Moving Average of the stock is -43.35%, while the 200-Day Moving Average is calculated to be -62.25%.
Shares Statistics:
It appears that SXTC traded 1.23M shares on average per day over the past three months and 4458040 shares per day over the past ten days. A total of 11.43M shares are outstanding, with a floating share count of 0.55M. Insiders hold about 3.13% of the company’s shares, while institutions hold 1.62% stake in the company. Shares short for SXTC as of 1711584000 were 26244 with a Short Ratio of 0.02, compared to 1709164800 on 82831. Therefore, it implies a Short% of Shares Outstanding of 26244 and a Short% of Float of 6.140000000000001.
Earnings Estimates
The current rating of China SXT Pharmaceuticals Inc (SXTC) reflects the combined expertise of Semtech Corporation analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $69.14, with high estimates of $60.52 and low estimates of $10.73.
